nicorandil has been researched along with Ovarian Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abe, H; Arimoto, T; Fujii, T; Katoh, M; Komuro, I; Oda, K; Osuga, Y; Takeda, N | 1 |
1 other study(ies) available for nicorandil and Ovarian Neoplasms
| Article | Year |
|---|---|
Bevacizumab-Related Microvascular Angina and Its Management with Nicorandil.
Topics: Angiogenesis Inhibitors; Bevacizumab; Coronary Angiography; Coronary Circulation; Dose-Response Relationship, Drug; Electrocardiography; Female; Follow-Up Studies; Humans; Microvascular Angina; Middle Aged; Nicorandil; Ovarian Neoplasms; Vasodilator Agents | 2017 |